A Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese Patients With First-line Advanced ESCC

by palligoelme@gmail.com | Jul 29, 2026 | Clinical Trials

​ Conditions: Advanced Esophageal Squamous Cell Carcinoma; Metastatic Esophageal Squamous Cell Carcinoma Interventions: Drug: Tislelizumab; Drug: Oxaliplatin; Drug: Leucovorin; Drug: 5-fluorouracil (5-FU) Sponsors: BeOne Medicines Not yet recruiting Conditions:...

Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies

by palligoelme@gmail.com | Jul 28, 2026 | Clinical Trials

​ Conditions: Food Addiction Tendency; Obesity; Overweight Interventions: Drug: Semaglutide Sponsors: Seoul National University Hospital Recruiting Conditions: Food Addiction Tendency; Obesity; Overweight Interventions: Drug: Semaglutide Sponsors: Seoul National...

Effect of Box Breathing Exercise on Anxiety, Pain, and Pulmonary Function Tests in Patients Undergoing Colonoscopy

by palligoelme@gmail.com | Jul 28, 2026 | Clinical Trials

​ Conditions: Colonoscopy Interventions: Other: box breathing exercises Sponsors: Tarsus University Not yet recruiting Conditions: Colonoscopy Interventions: Other: box breathing exercises Sponsors: Tarsus University Not yet...

Evaluation of a Paraclinical Test for the Diagnosis of Arterial Insufficiency in Diabetic Patients With Foot Ulcers

by palligoelme@gmail.com | Jul 28, 2026 | Clinical Trials

​ Conditions: Arterial Insufficiency Interventions: Procedure: Handheld Doppler Sponsors: Groupe Hospitalier de la Rochelle Ré Aunis Not yet recruiting Conditions: Arterial Insufficiency Interventions: Procedure: Handheld Doppler Sponsors: Groupe Hospitalier de la...

Study of ECC4703 With Sulfasalazine and Pitavastatin

by palligoelme@gmail.com | Jul 28, 2026 | Clinical Trials

​ Conditions: Non-alcoholic Fatty Liver Disease (NAFLD); Dyslipidaemia Interventions: Drug: ECC4703; Drug: Sulfasalazine; Drug: Pitavastatin Sponsors: Eccogene Not yet recruiting Conditions: Non-alcoholic Fatty Liver Disease (NAFLD); Dyslipidaemia Interventions: Drug:...

Symptom Management to Improve Completion of Patient-reported Outcome Measures

by palligoelme@gmail.com | Jul 28, 2026 | Clinical Trials

​ Conditions: Malignant Solid Neoplasm; Malignant Head and Neck Neoplasm; Malignant Lung Neoplasm Interventions: Behavioral: Monitoring of PROMIS symptoms and physical function; Behavioral: Monitoring of additional symptoms and symptom self-management Sponsors: Henry...